RXRX · Recursion Pharmaceuticals, Inc.
$3.57
+0.23 (+6.74%)
At close · Aug 21
Market Cap
$1.78B
Shares
535.34M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
318 filings
310 filers
Visit website
Investor relations